BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Diehl DL, Khara HS, Akhtar N, Critchley-Thorne RJ. TissueCypher Barrett's esophagus assay impacts clinical decisions in the management of patients with Barrett's esophagus. Endosc Int Open 2021;9:E348-55. [PMID: 33655033 DOI: 10.1055/a-1326-1533] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Iyer PG, Codipilly DC, Chandar AK, Agarwal S, Wang KK, Leggett CL, Rangel Latuche L, Schulte PJ. Prediction of Progression in Barrett's Esophagus Using a Tissue Systems Pathology Test: A Pooled Analysis of International Multicenter Studies. Clin Gastroenterol Hepatol 2022:S1542-3565(22)00190-2. [PMID: 35217151 DOI: 10.1016/j.cgh.2022.02.033] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Srinivasan S, Sharma P. Real-world data for endoscopic therapy in LGD: not looking so good. Gut 2021:gutjnl-2021-324544. [PMID: 34330785 DOI: 10.1136/gutjnl-2021-324544] [Reference Citation Analysis]
3 Choi WT, Lauwers GY, Montgomery EA. Utility of ancillary studies in the diagnosis and risk assessment of Barrett's esophagus and dysplasia. Mod Pathol 2022. [PMID: 35260826 DOI: 10.1038/s41379-022-01056-0] [Reference Citation Analysis]
4 Maslyonkina KS, Konyukova AK, Alexeeva DY, Sinelnikov MY, Mikhaleva LM. Barrett's esophagus: The pathomorphological and molecular genetic keystones of neoplastic progression. Cancer Med 2021. [PMID: 34870375 DOI: 10.1002/cam4.4447] [Reference Citation Analysis]